IRMD
Price
$53.25
Change
+$0.12 (+0.23%)
Updated
Apr 25, 02:04 PM (EDT)
Capitalization
557.04M
6 days until earnings call
NPCE
Price
$11.01
Change
-$0.24 (-2.13%)
Updated
Apr 25, 02:40 PM (EDT)
Capitalization
385.2M
18 days until earnings call
Ad is loading...

IRMD vs NPCE

Header iconIRMD vs NPCE Comparison
Open Charts IRMD vs NPCEBanner chart's image
iRadimed
Price$53.25
Change+$0.12 (+0.23%)
Volume$306
Capitalization557.04M
Neuropace
Price$11.01
Change-$0.24 (-2.13%)
Volume$100
Capitalization385.2M
IRMD vs NPCE Comparison Chart
Loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRMD vs. NPCE commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a Hold and NPCE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IRMD: $53.13 vs. NPCE: $11.25)
Brand notoriety: IRMD and NPCE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRMD: 91% vs. NPCE: 46%
Market capitalization -- IRMD: $557.04M vs. NPCE: $385.2M
IRMD [@Medical Specialties] is valued at $557.04M. NPCE’s [@Medical Specialties] market capitalization is $385.2M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 3 FA rating(s) are green whileNPCE’s FA Score has 0 green FA rating(s).

  • IRMD’s FA Score: 3 green, 2 red.
  • NPCE’s FA Score: 0 green, 5 red.
According to our system of comparison, IRMD is a better buy in the long-term than NPCE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 6 TA indicator(s) are bullish while NPCE’s TA Score has 4 bullish TA indicator(s).

  • IRMD’s TA Score: 6 bullish, 2 bearish.
  • NPCE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than NPCE.

Price Growth

IRMD (@Medical Specialties) experienced а +2.63% price change this week, while NPCE (@Medical Specialties) price change was +4.26% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.67%. For the same industry, the average monthly price growth was -4.68%, and the average quarterly price growth was -2.30%.

Reported Earning Dates

IRMD is expected to report earnings on Jul 31, 2025.

NPCE is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+4.67% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRMD($557M) has a higher market cap than NPCE($385M). NPCE YTD gains are higher at: 0.536 vs. IRMD (-3.107). IRMD has higher annual earnings (EBITDA): 20.8M vs. NPCE (-22.83M). NPCE has more cash in the bank: 66.5M vs. IRMD (49.8M). IRMD has less debt than NPCE: IRMD (2.04M) vs NPCE (72.4M). IRMD (65.6M) and NPCE (65.4M) have equivalent revenues.
IRMDNPCEIRMD / NPCE
Capitalization557M385M145%
EBITDA20.8M-22.83M-91%
Gain YTD-3.1070.536-579%
P/E Ratio31.84N/A-
Revenue65.6M65.4M100%
Total Cash49.8M66.5M75%
Total Debt2.04M72.4M3%
FUNDAMENTALS RATINGS
IRMD: Fundamental Ratings
IRMD
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRMDNPCE
RSI
ODDS (%)
Bullish Trend 2 days ago
56%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
59%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCDVX16.530.34
+2.10%
Calamos Dividend Growth C
ACFCX55.77N/A
N/A
American Century Focused Dynamic Gr R
GSPPX11.67N/A
N/A
Goldman Sachs Strategic Growth P
RMGYX10.57N/A
N/A
Russell Inv Multi-Asset Strat Y
MKVHX14.41N/A
N/A
MFS International Large Cap Value R6

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+0.76%
HBIO - IRMD
46%
Loosely correlated
-2.06%
VREX - IRMD
43%
Loosely correlated
+9.34%
AORT - IRMD
43%
Loosely correlated
+0.29%
ITGR - IRMD
41%
Loosely correlated
+0.79%
SIBN - IRMD
40%
Loosely correlated
+4.12%
More

NPCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with FNA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then FNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
+3.12%
FNA - NPCE
44%
Loosely correlated
N/A
STVN - NPCE
37%
Loosely correlated
+0.37%
IRMD - NPCE
33%
Poorly correlated
+0.76%
NTRA - NPCE
33%
Poorly correlated
+3.98%
HBIO - NPCE
32%
Poorly correlated
-2.06%
More